Pegylated recombinant human granulocyte colony‐stimulating factor regulates the immune status of patients with small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is an aggressive disease involving immunodeficiency for which chemotherapy is the standard treatment. Pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF) is widely used for primary or secondary prophylaxis of febrile neutropenia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jing, Bai, Hua, Wang, Zhijie, Duan, Jianchun, Li, Jin, Guo, Ruimin, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049512/
https://www.ncbi.nlm.nih.gov/pubmed/32020764
http://dx.doi.org/10.1111/1759-7714.13322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049512/
https://www.ncbi.nlm.nih.gov/pubmed/32020764
http://dx.doi.org/10.1111/1759-7714.13322

Ejemplares similares